Zahra Tavoosi, Hemen Moradi-sardareh, M. Saidijam, Reza Yadegarazari, S. Borzuei, A. Soltanian, M. Goodarzi
{"title":"Cholesterol Transporters ABCA1 and ABCG1 Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Metabolic Syndrome","authors":"Zahra Tavoosi, Hemen Moradi-sardareh, M. Saidijam, Reza Yadegarazari, S. Borzuei, A. Soltanian, M. Goodarzi","doi":"10.1155/2015/682904","DOIUrl":null,"url":null,"abstract":"ABCA1 and ABCG1 genes encode the cholesterol transporter proteins that play a key role in cholesterol and phospholipids homeostasis. This study was aimed at evaluating and comparing ABCA1 and ABCG1 genes expression in metabolic syndrome patients and healthy individuals. This case-control study was performed on 36 patients with metabolic syndrome and the same number of healthy individuals in Hamadan (west of Iran) during 2013-2014. Total RNA was extracted from mononuclear cells and purified using RNeasy Mini Kit column. The expression of ABCA1 and ABCG1 genes was performed by qRT-PCR. Lipid profile and fasting blood glucose were measured using colorimetric procedures. ABCG1 expression in metabolic syndrome patients was significantly lower (about 75%) compared to that of control group, while for ABCA1 expression, there was no significant difference between the two studied groups. Comparison of other parameters such as HDL-C, FBS, BMI, waist circumference, and systolic and diastolic blood pressure between metabolic syndrome patients and healthy individuals showed significant differences (P < 0.05). Decrease in ABCG1 expression in metabolic syndrome patients compared to healthy individuals suggests that hyperglycemia, related metabolites, and hyperlipidemia over the transporter capacity resulted in decreased expression of ABCG1. Absence of a significant change in ABCA1 gene expression between two groups can indicate a different regulation mechanism for ABCA1 expression.","PeriodicalId":72589,"journal":{"name":"Cholesterol","volume":"239 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cholesterol","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2015/682904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16
Abstract
ABCA1 and ABCG1 genes encode the cholesterol transporter proteins that play a key role in cholesterol and phospholipids homeostasis. This study was aimed at evaluating and comparing ABCA1 and ABCG1 genes expression in metabolic syndrome patients and healthy individuals. This case-control study was performed on 36 patients with metabolic syndrome and the same number of healthy individuals in Hamadan (west of Iran) during 2013-2014. Total RNA was extracted from mononuclear cells and purified using RNeasy Mini Kit column. The expression of ABCA1 and ABCG1 genes was performed by qRT-PCR. Lipid profile and fasting blood glucose were measured using colorimetric procedures. ABCG1 expression in metabolic syndrome patients was significantly lower (about 75%) compared to that of control group, while for ABCA1 expression, there was no significant difference between the two studied groups. Comparison of other parameters such as HDL-C, FBS, BMI, waist circumference, and systolic and diastolic blood pressure between metabolic syndrome patients and healthy individuals showed significant differences (P < 0.05). Decrease in ABCG1 expression in metabolic syndrome patients compared to healthy individuals suggests that hyperglycemia, related metabolites, and hyperlipidemia over the transporter capacity resulted in decreased expression of ABCG1. Absence of a significant change in ABCA1 gene expression between two groups can indicate a different regulation mechanism for ABCA1 expression.
ABCA1和ABCG1基因编码胆固醇转运蛋白,在胆固醇和磷脂稳态中起关键作用。本研究旨在评估和比较代谢综合征患者和健康个体中ABCA1和ABCG1基因的表达。本病例对照研究于2013-2014年在哈马丹(伊朗西部)对36例代谢综合征患者和相同数量的健康个体进行。从单个核细胞中提取总RNA,用RNeasy Mini Kit柱纯化。采用qRT-PCR检测ABCA1和ABCG1基因的表达。采用比色法测定血脂和空腹血糖。代谢综合征患者的ABCG1表达明显低于对照组(约75%),而ABCA1表达在两组间无显著差异。代谢综合征患者与健康人的HDL-C、FBS、BMI、腰围、收缩压、舒张压等指标比较差异有统计学意义(P < 0.05)。代谢综合征患者与健康人相比,ABCG1表达下降,提示高血糖、相关代谢物和转运体容量过高的高脂血症导致ABCG1表达下降。两组间ABCA1基因表达无明显变化,提示ABCA1表达调控机制不同。